Browsing Tag
Ardelyx Inc.
1 post
Zevra Therapeutics appoints new CFO. Is the rare disease biotech entering its next commercial cycle?
Zevra Therapeutics appoints Justin Renz as CFO as the rare disease biotech prepares for commercialization expansion. Read what the leadership move signals.